Clinically, CD10’s regulation of the natriuretic peptide (NP) pathway in the heart positions it as a potential biomarker and therapeutic target for heart failure (HF) (Bayes-Genis et al., 2016; Arrigo et al., 2018). Here, MME is linked to heart failure.